Nautilus Biotechnology, Inc.
NAUT
$2.35
$0.020.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 9.71% | -0.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.54% | -0.31% | |||
| Operating Income | -4.54% | 0.31% | |||
| Income Before Tax | -6.65% | -1.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.65% | -1.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.65% | -1.52% | |||
| EBIT | -4.54% | 0.31% | |||
| EBITDA | -5.13% | 0.18% | |||
| EPS Basic | -6.42% | -1.49% | |||
| Normalized Basic EPS | -5.38% | -2.38% | |||
| EPS Diluted | -6.42% | -1.49% | |||
| Normalized Diluted EPS | -5.38% | -2.38% | |||
| Average Basic Shares Outstanding | 0.21% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.21% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||